Machine learning and artificial intelligence are set to play a significant role in the future of drug development. Recent research has unveiled new insights into how these models should be supervised, using both so-called positive and negative data.
"Digitized antibody". Illustration image: Rahmad Akbar.
By
Elin Martine Doeland
/University of Oslo Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
